Who will conduct the fourth clinical trial of new drugs after the patent application for drugs? Is it necessary to conduct clinical trials after patent application (applicant or pharmaceutical factory)?
A prescription of a drug can only apply for the invention patent in the patent, and the cost of a single application is 3500-5000 yuan * * *. Generally, the more experienced the agent, the older the seniority, the higher the price, and of course the quality of writing is relatively good. There are two ways to transfer pharmaceutical patents: the transfer of the right to apply (the risk of disclosure is high) and the transfer after the applicant applies. Generally, valuable patent applications can be transferred.
There is no direct relationship between clinical trials of new drugs and patent applications. The patent application only shows that the applicant first discovered the formula, which does not mean that the formula must have no side effects or can pass the clinic smoothly. They are independent of each other, that is, patent knowledge protects your right to find the drug effectively first, while clinical trials belong to the process of medical management.